Novadaq Technologies, Inc. to Present on SPY Imaging at Needham Healthcare Conference

TORONTO, ONTARIO--(Marketwire - June 07, 2010) - Novadaq® Technologies Inc. (TSX: NDQ), a developer of real-time imaging systems for use in the operating room, today announced Dr. Arun Menawat, Chief Executive Officer, will present a live webcast during the 9th Annual Needham Healthcare Conference at 9:20 a.m. (Eastern) on Thursday, June 10, 2010 at the New York Palace Hotel, New York, New York.

Needham and Company, LLC’s 9th Annual Healthcare Conference is a forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostic sectors.

One-on-one meetings with Novadaq are available during the conference on June 10, after 10 a.m. (Eastern). For those who are unable to attend, a webcast will be available on www.novadaq.com.

About Novadaq Technologies Inc.

Novadaq develops and markets real-time fluorescence imaging systems for the operating room. The company’s core product, the SPY imaging system, is installed in approximately 100 hospitals in the United States. According to over 40 published journal articles, surgeons use SPY imaging for guidance during complex procedures to visualize vascular blockages; assess tissue perfusion; identify cancerous tumors and delineate margins; and visualize relevant lymph nodes for removal. Studies have shown conclusively that use of SPY imaging in plastic reconstruction, gastrointestinal and cardiac surgery procedures improves clinical outcomes and reduces costs of complications, demonstrating significant patient and economic value. Novadaq has an alliance with Intuitive Surgical in late stage development to incorporate SPY imaging into the da Vinci robotic system. Novadaq’s minimally invasive imaging system is also in clinical development stage.

Forward-Looking Statements

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.